ArticleNPJ precision oncology2026

Multi-omics profiling identifies triciribine as a biomarker-guided antimetabolite therapy for acute lymphoblastic leukemia.

Xuekang Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.